CMV pp65 and IE-1 T cell epitopes recognized by healthy subjects

BACKGROUND: Adoptive immune and vaccine therapies have been used to prevent cytomegalovirus (CMV) disease in recipients of hematopoietic progenitor cell transplants, but the nature of T cell responses to CMV have not been completely characterized. METHODS: Peptide pools and individual peptides deriv...

Descripción completa

Detalles Bibliográficos
Autores principales: Slezak, Stefanie L, Bettinotti, Maria, Selleri, Silvia, Adams, Sharon, Marincola, Francesco M, Stroncek, David F
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1851947/
https://www.ncbi.nlm.nih.gov/pubmed/17391521
http://dx.doi.org/10.1186/1479-5876-5-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1851947/
https://www.ncbi.nlm.nih.gov/pubmed/17391521
http://dx.doi.org/10.1186/1479-5876-5-17

Ejemplares similares